Citation Impact
Citing Papers
Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38
2008
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
Intensive versus Conventional Glucose Control in Critically Ill Patients
2009 Standout
Characteristics and Roles of Exosomes in Cardiovascular Disease
2017
The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation
2016
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Acute Coronary Care in the Elderly, Part I
2007
The effects of compensated cardiac hypertrophy on dihydropyridine and ryanodine receptors in rat, ferret and guinea-pig hearts
1995
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
Effects of Beta Blockade on Sudden Cardiac Death During Acute Myocardial Infarction and the Postinfarction Period
1997
Diabetes as a risk factor for myocardial infarction: population and gender perspectives
1997
Arrhythmias and mortality in congestive heart failure
1990
Effect of Beta Blockers, Particularly Carvedilol, on Reducing the Risk of Events After Acute Myocardial Infarction
2006
Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials
2015
Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study
2002
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
2010 Standout
Inflammation and metabolic disorders
2006 StandoutNature
Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus
1997
Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control*
2003 Standout
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
1996 Standout
Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non–ST-segment elevation acute coronary syndrome
2013
Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart.
1988
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1992 Standout
Quantitative Echocardiographic Analysis of the Right Ventricle in Healthy Individuals
2006
Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions Potential for pharmacological interventions
1997
Acute hyperglycemia exacerbates myocardial ischemia/reperfusion injury and blunts cardioprotective effect of GIK
2007
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 Standout
The impact of ageing on right ventricular longitudinal function in healthy subjects: a pulsed tissue Doppler study
2008
Mortality prediction in diabetic patients with myocardial infarction: experiences from the DIGAMI study
1997
Insulin‐based regimens decrease mortality rates in critically ill patients: a systematic review
2006
Antiarrhythmic effect of carvedilol after acute myocardial infarction
2005
How does blood glucose control with insulin save lives in intensive care?
2004
Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia–reperfusion injury in rats
2006
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
1998 Standout
Management of Hyperglycemia in the Hospital Setting
2006
Hyperglycemia and its effect after acute myocardial infarction on cardiovascular outcomes in patients with Type 2 diabetes mellitus (HEART2D)
2005
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Metabolic manipulation in ischaemic heart disease, a novel approach to treatment
2004
Severe Hypoglycemia Monitoring and Risk Management Procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
2007
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Molecular Insights into the Biosynthesis of Guadinomine: A Type III Secretion System Inhibitor
2012 StandoutNobel
Influence of Diabetes Mellitus on Clinical Outcome in the Thrombolytic Era of Acute Myocardial Infarction fn1fn1The GUSTO-I study was supported by a combined grant from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genetech, South San Francisco, California; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.
1997
Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting
2003
The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus
2001
Role for TNF in atherosclerosis? Lessons from autoimmune disease
2009
Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials
2006
Successes and failures of current treatment of heart failure
1998
Comparison of Treatment and Outcome of Acute Coronary Syndrome in Patients With Versus Patients Without Diabetes Mellitus
2009
Anemia is an independent risk for mortality after acute myocardial infarction in patients with and without diabetes
2006
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Biology of the troponin complex in cardiac myocytes
2004
Gut metagenome in European women with normal, impaired and diabetic glucose control
2013 StandoutNature
Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction
2003
Stress-Induced Hyperglycemia
2001
Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
2007
Glucose and insulin improve cardiac efficiency and postischemic functional recovery in perfused hearts from type 2 diabetic (db/db) mice
2007
Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis
2006
The Effects of Improved Glycemic Control on Complications in Type 2 Diabetes
1998
The echocardiographic assessment of the right ventricle: what to do in 2010?
2010
Relation between beta-adrenergic blocker use, various correlates of left ventricular function and the chance of developing congestive heart failure
1990
Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes
2014
Stem Cell-Derived Exosome in Cardiovascular Diseases: Macro Roles of Micro Particles
2018
Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era
2006
HOSPITAL MANAGEMENT OF DIABETES
2000
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
2008 Standout
Seven-transmembrane-spanning receptors and heart function
2002 StandoutNatureNobel
Long-term Pharmacological Activation of PPARγDoes not Prevent Left Ventricular Remodeling in Dogs with Advanced Heart Failure
2007
Mechanisms, diagnosis, and treatment of diastolic heart failure
1995
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Extracellular vesicles as drug delivery systems: Lessons from the liposome field
2014
Absence of a deleterious effect of calcium channel blockers in patients with left ventricular dysfunction after myocardial infarction: The SAVE study experience
1998
Exosomes as Diagnostic Biomarkers in Cardiovascular Diseases
2017
Echocardiographic Indexes for the Non-Invasive Evaluation of Pulmonary Hemodynamics
2010
Targeted Anticytokine Therapy and the Failing Heart
2005
Tight Glycemic Control Reduces Heart Inflammation and Remodeling During Acute Myocardial Infarction in Hyperglycemic Patients
2009
Association between hyperglycemia and the no-reflow phenomenon inpatients with acute myocardial infarction
2002
Quantifying heterogeneity in a meta‐analysis
2002 Standout
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
Biomarkers in Heart Failure
2008 Standout
Extracellular vesicle-mediated transfer of donor genomic DNA to recipient cells is a novel mechanism for genetic influence between cells
2013
Perfused hearts from Type 2 diabetic (db/db) mice show metabolic responsiveness to insulin
2005
Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome
2011
Intensive Insulin Therapy in Critically Ill Patients
2001 Standout
Effects of acute hyperglycemia on myocardial glycolytic activity in humans.
1990
Bias in meta-analysis detected by a simple, graphical test
1997 Standout
Glucose-Insulin-Potassium Reduces Infarct Size When Administered During Reperfusion
2000
Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography
2010 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Intensive Insulin Therapy in the Medical ICU
2006 Standout
The immunopathogenesis of sepsis
2002 StandoutNature
Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview
2000 Standout
Diabetes mellitus and congestive heart failure
1999
A small-molecule inhibitor of the bacterial type III secretion system protects against in vivo infection with Citrobacter rodentium
2010 StandoutNobel
Management of Diabetes and Hyperglycemia in Hospitals
2004
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Diagnosing diastolic heart failure
2002
Glucose-Insulin-Potassium Therapy for Treatment of Acute Myocardial Infarction
1997
Impact of Diabetes on Mortality After the First Myocardial Infarction
1998
Glucose Potassium Insulin Infusions in the Treatment of Acute Stroke Patients With Mild to Moderate Hyperglycemia
1999
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)
2007
Cardioselective beta-blockers for chronic obstructive pulmonary disease
2005
Creatine Kinase System in Failing and Nonfailing Human Myocardium
1996
Ventricular dysfunction and necrosis produced by adrenochrome metabolite of epinephrine: Relation to pathogenesis of catecholamine cardiomyopathy
1981
Effect of Obesity and Insulin Resistance on Myocardial Substrate Metabolism and Efficiency in Young Women
2004
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome
2011
Evaluating the federal role in financing health-related research
1996 StandoutNobel
Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus
2004 Standout
Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events
2005
Epinephrine-induced hypokalemia: The role of beta adrenoceptors
1986
Insulin Therapy for Critically Ill Hospitalized Patients
2004
Depressed intracellular calcium transients and contraction in myocytes from hypertrophied and failing guinea pig hearts
1991
Glycaemic control in acute coronary syndromes: prognostic value and therapeutic options
2010
Ambulatory (Holter) Electrocardiography Technology
1992
Long-term prognostic value of mitral regurgitation in acute coronary syndromes
2010
Metabolic Modulation of Acute Myocardial Infarction
1998
Effects of Stress Hyperglycemia on Acute Myocardial Infarction
2003
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Hormone-electrolyte interactions in the pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure: Basis of a new physiologic approach to control of arrhythmia
1986
Adrenergic effects on the biology of the adult mammalian cardiocyte.
1992
The Need for Glycemic Trials in Type 2 Diabetes
2003
Restoration of β-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer
1997 StandoutNobel
Identification of simple arylfluorosulfates as potent agents against resistant bacteria
2021 StandoutNobel
Beta blockade during and after myocardial infarction: An overview of the randomized trials
1985 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
The Seattle Heart Failure Model
2006
ATPase activity of the cross-linked complex between cardiac myosin subfragment 1 and actin in several models of chronic overloading. A new approach to the biochemistry of contractility.
1989
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
2000 Standout
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
Sudden cardiac death: the lost fatty acid hypothesis
2006
Influence of free fatty acids on myocardial oxygen consumption and ischemic injury
1981
β2-Adrenergic Receptor Antagonists Protect Against Ventricular Fibrillation
1997
Heart Rate Variability
1996 Standout
Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic mice
2009 StandoutNobel
Effect of propranolol after acute myocardial infarction in patients with congestive heart failure.
1986
Oxfenicine diverts rat muscle metabolism from fatty acid to carbohydrate oxidation and protects the ischaemic rat heart
1980
17-beta-estradiol therapy lessens angina in postmenopausal women with syndrome X
1996
Inhibition of Adenylyl Cyclase by G iα
1993 StandoutScienceNobel
Declining incidence of ventricular fibrillation in myocardial infarction. Implications for the prophylactic use of lidocaine.
1992
Molecular Mechanisms of Myocardial Remodeling
1999 Standout
Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction
1999
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study.
1991
Expert consensus document on ?-adrenergic receptor blockersThe Task Force on Beta-Blockers of the European Society of Cardiology
2004
Creatine and Creatinine Metabolism
2000 Standout
Evidence for Cardiomyocyte Renewal in Humans
2009 StandoutScience
Works of Anders Waldenström being referenced
Deletion in the Cardiac Troponin I Gene in a Family From Northern Sweden with Hypertrophic Cardiomyopathy
2000
Parasympathetic muscarinic stimulation limits noradrenaline induced myocardial creatine kinase release: A study in the isolated perfused working rat heart
1994
Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction
1996
Myocardial Insulin-mediated Glucose Uptake and Left Ventricular Geometry
2001
Cardiomyocyte Microvesicles Contain DNA/RNA and Convey Biological Messages to Target Cells
2012
Lower threshold for adenosine-induced chest pain in patients with angina and normal coronary angiograms
1992
Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle
2007
Prognostic implications of hypoglycaemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial
2008
Regional and Global Right Ventricular Function in Healthy Individuals Aged 20–90 Years: A Pulsed Doppler Tissue Imaging Study
Umeå General Population Heart Study
2005
Right ventricular dysfunction in hypertrophic cardiomyopathy as evidenced by the myocardial performance index
2007
Pulsed tissue Doppler and strain imaging discloses early signs of infiltrative cardiac disease: A study on patients with familial amyloidotic polyneuropathy
2005
Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year
1995 Standout
New concept in echocardiography: harmonic imaging of tissue without use of contrast agent
1998
Adequacy of diagnosis and treatment of chronic heart failure in primary health care in Sweden
2009
Major alterations in relaxation during cardiac hypertrophy induced by aortic stenosis in guinea pig.
1987
A possible role of noradrenaline in the development of myocardial infarction
1978
Role of Exosomes in Myocardial Remodeling
2014
Göteborg Metoprolol Trial: design, patient characteristics and conduct.
1984
Right ventricular myocardial isovolumic relaxation time and pulmonary pressure
2005
Improved Myocardial Protection during Cold Cardioplegia by Means of Increased Myocardial Glycogen Stores1
1982
A Double-Blind Trial of Metoprolol in Acute Myocardial Infarction
1983
Development of congestive heart failure after treatment with metoprolol in acute myocardial infarction.
1984
The effects of hyperinsulinaemia on myocardial mass, blood pressure regulation and central haemodynamics in rats
1996
Factors Modifying Ischemic Injury in the Isolated Rat Heart
1977
Abnormalities of adrenergic and muscarinic receptor control of human myocardial membranes in idiopathic dilated cardiomyopathy
1985
Limitation of infarct size in acute myocardial infarction with metoprolol
1982
EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTION
1981
The reliability of intermittent ECG sampling in arrhythmia detection.
1975
Myocardial enzyme release from ischemic isolated perfused working rat heart.
1975
Targeted Anticytokine Therapy in Patients With Chronic Heart Failure
2004
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity
2005